Frequently Asked Questions

Ignite Health is a cash-pay practice, which allows for more time, personalization, and flexibility in your care. You may use your commercial insurance for medications, diagnostic testing, and labs. We do not bill or accept commercial insurance, Medicare, or Medicaid for services. We have opted out of Medicare, so beneficiaries may receive care under a private-pay agreement.

We accept all major credit cards, as well as FSA and HSA cards.
Payments are processed securely through a HIPAA-compliant system.

Many of the hormones I prescribe are bioidentical, meaning they are chemically identical to the hormones your body naturally makes.

That said, the term “bioidentical” is often used loosely in marketing, so what matters most is how the hormone is formulated, dosed, and monitored — not just the label.

I use evidence-based, FDA-approved options when possible and may also use compounded formulations when there is a clear clinical reason. The goal is always safety, effectiveness, and personalization — not a one-size-fits-all approach.

Yes. GLP-1 medications may be included in your personalized plan when clinically appropriate.

Ignite Health is a virtual practice providing telehealth services to the states of:
Florida, Maryland, Washington DC, Delaware, and Colorado.

Yes. Testosterone may be considered for appropriately selected women with low sexual desire. Treatment is guided by evidence-based recommendations, including those of The Menopause Society, and is carefully dosed and monitored.

Yes. When appropriate, I can review thyroid testing and manage straightforward thyroid medication needs as part of your midlife care.

Yes. I have completed advanced training specifically in menopause care, hormone therapy, and breast cancer management. Women with a history of breast cancer deserve an individualized discussion rather than an automatic yes or no.

Treatment decisions depend on factors such as the type of breast cancer, receptor status, current or prior cancer treatment, severity of symptoms, personal risk factors, and the woman’s own priorities. Care may include nonhormonal options, treatment for genitourinary symptoms, and, when appropriate, collaboration with her oncology team.